BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 23354654)

  • 21. Genomic deletions in cell lines derived from primitive neuroectodermal tumors of the central nervous system.
    Dallas PB; Terry PA; Kees UR
    Cancer Genet Cytogenet; 2005 Jun; 159(2):105-13. PubMed ID: 15899381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating H3F3A K27M and G34R/V somatic mutations in a cohort of pediatric brain tumors of different and rare histologies.
    Oliveira VF; De Sousa GR; Dos Santos AC; Saggioro FP; Machado HR; de Oliveira RS; Tone LG; Valera ET
    Childs Nerv Syst; 2021 Feb; 37(2):375-382. PubMed ID: 32766947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular genetic analysis of the TP53, PTEN, CDKN2A, EGFR, CDK4 and MDM2 tumour-associated genes in supratentorial primitive neuroectodermal tumours and glioblastomas of childhood.
    Kraus JA; Felsberg J; Tonn JC; Reifenberger G; Pietsch T
    Neuropathol Appl Neurobiol; 2002 Aug; 28(4):325-33. PubMed ID: 12175345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytogenetic analysis of 109 pediatric central nervous system tumors.
    Neumann E; Kalousek DK; Norman MG; Steinbok P; Cochrane DD; Goddard K
    Cancer Genet Cytogenet; 1993 Nov; 71(1):40-9. PubMed ID: 8275451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutation analysis and loss of heterozygosity of PEDF in central nervous system primitive neuroectodermal tumors.
    Slavc I; Rodriguez IR; Mazuruk K; Chader GJ; Biegel JA
    Int J Cancer; 1997 Jul; 72(2):277-82. PubMed ID: 9219833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malignant glioma with primitive neuroectodermal tumor-like component (MG-PNET): novel microarray findings in a pediatric patient.
    Liu J; Keisling MP; Samkari A; Halligan G; Pascasio JM; Katsetos CD
    Clin Neuropathol; 2016; 35(6):353-367. PubMed ID: 27781423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiological and Immunostaining Characteristics of H3.3 G34R-Mutant Glioma: A Report of 3 Cases and Review of the Literature.
    Onishi S; Amatya VJ; Karlowee V; Takeshima Y; Sugiyama K; Kurisu K; Yamasaki F
    Pediatr Neurosurg; 2020; 55(5):319-325. PubMed ID: 33227796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primitive neuroectodermal tumors of the brainstem in children treated according to the HIT trials: clinical findings of a rare disease.
    Friedrich C; Warmuth-Metz M; von Bueren AO; Nowak J; Bison B; von Hoff K; Pietsch T; Kortmann RD; Rutkowski S
    J Neurosurg Pediatr; 2015 Mar; 15(3):227-35. PubMed ID: 25555122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma.
    Schwartzentruber J; Korshunov A; Liu XY; Jones DT; Pfaff E; Jacob K; Sturm D; Fontebasso AM; Quang DA; Tönjes M; Hovestadt V; Albrecht S; Kool M; Nantel A; Konermann C; Lindroth A; Jäger N; Rausch T; Ryzhova M; Korbel JO; Hielscher T; Hauser P; Garami M; Klekner A; Bognar L; Ebinger M; Schuhmann MU; Scheurlen W; Pekrun A; Frühwald MC; Roggendorf W; Kramm C; Dürken M; Atkinson J; Lepage P; Montpetit A; Zakrzewska M; Zakrzewski K; Liberski PP; Dong Z; Siegel P; Kulozik AE; Zapatka M; Guha A; Malkin D; Felsberg J; Reifenberger G; von Deimling A; Ichimura K; Collins VP; Witt H; Milde T; Witt O; Zhang C; Castelo-Branco P; Lichter P; Faury D; Tabori U; Plass C; Majewski J; Pfister SM; Jabado N
    Nature; 2012 Jan; 482(7384):226-31. PubMed ID: 22286061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Base-resolution methylomes of gliomas bearing histone H3.3 mutations reveal a G34 mutant-specific signature shared with bone tumors.
    Sangatsuda Y; Miura F; Araki H; Mizoguchi M; Hata N; Kuga D; Hatae R; Akagi Y; Amemiya T; Fujioka Y; Arai Y; Yoshida A; Shibata T; Yoshimoto K; Iihara K; Ito T
    Sci Rep; 2020 Sep; 10(1):16162. PubMed ID: 32999376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Supratentorial CNS-PNETs in children; a Swedish population-based study with molecular re-evaluation and long-term follow-up.
    Schepke E; Löfgren M; Pietsch T; Kling T; Nordborg C; Olsson Bontell T; Holm S; Öberg A; Nyman P; Eliasson-Hofvander M; Sabel M; Lannering B; Carén H
    Clin Epigenetics; 2023 Mar; 15(1):40. PubMed ID: 36895035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the WNT/β-catenin pathway in central nervous system primitive neuroectodermal tumours (CNS PNETs).
    Rogers HA; Ward JH; Miller S; Lowe J; Coyle B; Grundy RG
    Br J Cancer; 2013 May; 108(10):2130-41. PubMed ID: 23591193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3 K27M Mutation.
    Aboian MS; Solomon DA; Felton E; Mabray MC; Villanueva-Meyer JE; Mueller S; Cha S
    AJNR Am J Neuroradiol; 2017 Apr; 38(4):795-800. PubMed ID: 28183840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms.
    Judkins AR; Mauger J; Ht A; Rorke LB; Biegel JA
    Am J Surg Pathol; 2004 May; 28(5):644-50. PubMed ID: 15105654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system.
    Reifenberger J; Wolter M; Weber RG; Megahed M; Ruzicka T; Lichter P; Reifenberger G
    Cancer Res; 1998 May; 58(9):1798-803. PubMed ID: 9581815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reciprocal H3.3 gene editing identifies K27M and G34R mechanisms in pediatric glioma including NOTCH signaling.
    Chen KY; Bush K; Klein RH; Cervantes V; Lewis N; Naqvi A; Carcaboso AM; Lechpammer M; Knoepfler PS
    Commun Biol; 2020 Jul; 3(1):363. PubMed ID: 32647372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a novel antibody to define histone 3.3 G34R mutant brain tumours.
    Haque F; Varlet P; Puntonet J; Storer L; Bountali A; Rahman R; Grill J; Carcaboso AM; Jones C; Layfield R; Grundy RG
    Acta Neuropathol Commun; 2017 Jun; 5(1):45. PubMed ID: 28587626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials.
    Liu APY; Dhanda SK; Lin T; Sioson E; Vasilyeva A; Gudenas B; Tatevossian RG; Jia S; Neale G; Bowers DC; Hassall T; Partap S; Crawford JR; Chintagumpala M; Bouffet E; McCowage G; Broniscer A; Qaddoumi I; Armstrong G; Wright KD; Upadhyaya SA; Vinitsky A; Tinkle CL; Lucas J; Chiang J; Indelicato DJ; Sanders R; Klimo P; Boop FA; Merchant TE; Ellison DW; Northcott PA; Orr BA; Zhou X; Onar-Thomas A; Gajjar A; Robinson GW
    Acta Neuropathol; 2022 Oct; 144(4):733-746. PubMed ID: 35982322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The multiple tumor suppressor 1/cyclin-dependent kinase inhibitor 2 gene in human central nervous system primitive neuroectodermal tumor.
    Raffel C; Ueki K; Harsh GR; Louis DN
    Neurosurgery; 1995 May; 36(5):971-4; discussion 974-5. PubMed ID: 7791990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation Between Immunohistochemistry and Sequencing in H3G34-Mutant Gliomas.
    Gianno F; Antonelli M; Di Dio T; Minasi S; Donofrio V; Buccoliero AM; Gardiman MP; Pollo B; Diomedi Camassei F; Rossi S; Novello M; Giangaspero F; Arcella A; Gessi M; Buttarelli FR
    Am J Surg Pathol; 2021 Feb; 45(2):200-204. PubMed ID: 33428336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.